Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 6911-6920 of 13616

Page
per page
  1. Tibolone
    C4946 Tibolone
    Summary: An agonist that modulates hormone receptor activity for postmenopausal osteoporosis research.
  2. Pilaralisib
    C9087 Pilaralisib
    Summary: A reversible, selective class I PI3K inhibitor with preference for p110α/δ/γ, for research use.
      ≥52.7 mg/mL
  3. Vorapaxar
    A8809 Vorapaxar
    Target: Protease-Activated Receptors
    Summary: PAR-1 antagonist,potent and orally active
      ≥24.65 mg/mL
  4. BRL-54443
    B2245 BRL-54443
    Summary: 5-HT1E/1F receptor agonist,potent and selective
      Soluble in DMSO
  5. Anidulafungin
    B1224 Anidulafungin
     1 Citation
    Target: Glucan synthase
    Summary: Antifungal drug
      insoluble in EtOH; insoluble in H2O; ≥20.8 mg/mL
  6. b-Casomorphin (1-3)
    A1011 b-Casomorphin (1-3)
    Summary: Milk protein casein analog, have an opioid effect
      ≥13.46 mg/mL
  7. 4-Methylbenzylidene camphor
    C3558 4-Methylbenzylidene camphor
    Summary: ultraviolet light blocker used in cosmetics and sunscreen preparations that also has estrogenic activities.
      insoluble in H2O; ≥10 mg/mL
  8. Cdk4/6 Inhibitor IV
    C3995 Cdk4/6 Inhibitor IV
    Summary: Cdk4/cyclin D1 and Cdk6/cyclin D1 inhibitor
      ≤1 mg/mL
  9. 4-methyl Erlotinib
    C4727 4-methyl Erlotinib
    Summary: EGFR inhibitor
      ≤0.25 mg/mL
  10. Tolmetin (sodium salt hydrate)
    C4720 Tolmetin (sodium salt hydrate)
    Summary: non-steroidal anti-inflammatory drug that non-selectively inhibits human COX-1 and -2
      ≥7.83 mg/mL

Items 6911-6920 of 13616

Page
per page